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Background: Phospholipids containing 
polyunsaturated hydrocarbon chain play 
important roles in various biological 
membranes. 
Results: Fluorescence microscopic analysis 
with a chemically synthesized fluorescent probe 
showed localization of phospholipids containing 
an eicosapentaenyl group at the bacterial cell 
division site. 
Conclusion: Phospholipids containing 
polyunsaturated hydrocarbon chain form a 
membrane microdomain at the cell center to 
promote cell division. 
Significance: Hydrocarbon-chain-dependent 
microdomain formation was visualized in vivo. 
 
SUMMARY 
We found in this study that 
phospholipids containing an eicosapentaenyl 
group form a novel membrane microdomain 
at the cell division site of a Gram-negative 
bacterium, Shewanella livingstonensis Ac10, 
by using chemically synthesized fluorescent 
probes. The occurrence of membrane 
microdomains in eukaryotes and prokaryotes 
has been demonstrated with various imaging 
tools for phospholipids with different polar 
head groups. However, little has been studied 
regarding hydrocarbon-chain-dependent 
localization of membrane-resident 
phospholipids in vivo. We previously found 
that lack of eicosapentaenoic acid (EPA), a 
polyunsaturated fatty acid found at the sn-2 
position of glycerophospholipids, causes a 
defect in cell division after DNA replication 
of S. livingstonensis Ac10. Here, we 
synthesized phospholipid probes labeled with 
a fluorescent 7-nitro-2,1,3-benzoxadiazol-4-yl 
(NBD) group to study the localization of 
EPA-containing phospholipids by 
fluorescence microscopy. A fluorescent probe, 
in which EPA is bound to the glycerol 
backbone via an ester bond, was found to be 
unsuitable for imaging because EPA was 
released from the probe by in vivo hydrolysis. 
To overcome this problem, we synthesized 
hydrolysis-resistant ether-type phospholipid 
probes. Using these probes, we found that the 
fluorescence localized between two nucleoids 
at the cell center during cell division when 
the cells were grown in the presence of the 
eicosapentaenyl-group-containing probe 
(N-NBD-1-oleoyl-2-eicosapentaenyl-sn-glycer
o-3-phosphoethanolamine), whereas this 
localization was not observed with the 
oleyl-group-containing control probe 
(N-NBD-1-oleoyl-2-oleyl-sn-glycero-3-phosph
oethanolamine). Thus, phospholipids 
containing an eicosapentaenyl group are 
specifically enriched at the cell division site. 
Formation of a membrane microdomain 
enriched in EPA-containing phospholipids at 
the nucleoid occlusion site probably 
facilitates cell division. 
 
Biological membranes are composed of 
lipids and proteins and play essential roles in all 
living organisms in nutrient uptake, waste efflux, 
signal transduction, morphogenesis, etc. 
According to the fluid mosaic model proposed 
by Singer and Nicolson (1), it was previously 
assumed that lipids are homogeneously 
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distributed in biological membranes. However, 
this view was considerably modified by the 
discovery of membrane microdomains, each of 
which is supposed to have specific physiological 
functions. 
Various lipid molecules form membrane 
microdomains in eukaryotes and prokaryotes. 
Eukaryotic cells contain membrane 
microdomains, known as lipid rafts, that are 
enriched in sphingolipids and sterols (2). Lipid 
rafts serve as platforms for the colocalization of 
proteins involved in signaling and transport. In 
prokaryotes, cardiolipin microdomains exist at 
the poles and septa in the rod-shaped cells of 
Escherichia coli, Bacillus subtilis, and 
Pseudomonas putida (3, 4). Recently, the 
membrane of B. subtilis was reported to contain 
microdomains functionally similar to the lipid 
rafts of eukaryotic cells (5). These observations 
indicate the importance of dissecting the 
distribution of individual lipid molecules in 
biological membranes to better understand the 
mechanisms behind biological phenomena 
observed at the cell membrane. 
Long-chain ω-3 polyunsaturated fatty acids, 
eicosapentaenoic acid (EPA, 20:5 5,8,11,14,17 all cis) 
and docosahexaenoic acid (DHA, 22:6 
4,7,10,13,16,19 all cis), have been attracting a great deal 
of attention mainly because of their beneficial 
effects on human health (6-8). EPA and DHA 
occur in the membranes of various organisms, 
including mammals and bacteria, as acyl chains 
of phospholipids. EPA and DHA serve as 
precursors of various eicosanoids and autacoids 
(9). DHA interacts with membrane-associated G 
protein-coupled receptors to support their 
function (10-12). In EPA-producing bacteria, 
EPA plays a beneficial role in cell division (13, 
14). However, the molecular mechanisms of 
EPA and DHA action are not well defined, in 
particular, their roles in coordinating the spatial 
organization of the phospholipids that contain 
them in biological membranes. 
A Gram-negative bacterium, Shewanella 
livingstonensis Ac10, which produces EPA as 
an sn-2 acyl chain of phosphatidylethanolamine 
(PE) and phosphatidylglycerol (PG) (13, 15), is 
an excellent model organism for the studies on 
in vivo EPA function because of the following 
(13, 15-17): (i) The genes coding for EPA 
synthase are known, enabling the construction 
of an EPA-less mutant by disruption of these 
genes. (ii) The phenotype of the EPA-less 
mutant is clear; depletion of EPA causes growth 
retardation at low temperatures and produces 
filamentous cells because of a defect in cell 
division. (iii) The structure-function relationship 
of EPA can be studied by externally adding a 
series of EPA analogs to the culture medium. 
(iv) The whole genome sequence is available for 
this bacterium. (v) The methods for the genetic 
manipulation of this bacterium have been 
established. (vi) As a bacterium, it has a much 
simpler membrane system than eukaryotic cells. 
To gain more insight into the function of 
the EPA-containing phospholipids in the cell 
membrane, we synthesized fluorescent 
molecular probes in this study to visualize the 
distribution of phospholipids containing 
polyunsaturated hydrocarbon chains. Recently, 
advances in the methods for labeling small 
molecules to visualize their subcellular 
localization have been made. For phospholipids, 
methods have been reported for visualization of 
phosphatidylserine (18), 
phosphatidylethanolamine (19), 
phosphatidylcholine (20, 21), phosphatidic acid 
(22), and sphingomyelin (21, 23). However, 
hydrocarbon chain-dependent localization of 
phospholipids cannot be visualized by using 
currently available molecular probes. To 
achieve this, we introduced a fluorescent group 
into the head group of phospholipids. A 
polyunsaturated hydrocarbon chain was bound 
to the phospholipids via an ether bond (an ester 
bond did not work because it was hydrolyzed in 
S. livingstonensis Ac10, resulting in the release 
of the polyunsaturated hydrocarbon chain from 
the probe molecule). By using this fluorescent 
probe, we found that phospholipids with an 
eicosapentaenyl group are enriched at the cell 
division site of S. livingstonensis Ac10. This is 
in accordance with the physiological function of 
EPA-containing phospholipids in the cell 
division of this bacterium. These results greatly 
contribute to understanding the in vivo function 
of polyunsaturated fatty acids and indicate the 
usefulness of the probe we synthesized. 
 
EXPERIMENTAL PROCEDURES 
Synthesis of fluorescent phospholipid 
probes -- 7-Nitro-2,1,3-benzoxadiazol-4-yl 
(NBD)-labeled phospholipids shown in Fig. 1 
were chemically synthesized according to the 
methods described in Supplemental Data. 
Bacterial strain and growth conditions -- 
The EPA-less mutant of S. livingstonensis Ac10 
used in this study was constructed by the 
disruption of orf5, one of the genes required for 
EPA synthesis (13). We previously found that 
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this EPA-less mutant is longer than the 
wild-type strain because of retardation of cell 
division after DNA replication; this longer 
bacterial length facilitates microscopic analysis 
of the phospholipid subcellular localization, as 
fluorescence microscopic analysis of the much 
shorter wild-type strain cells is difficult. The 
cells were grown in LB medium containing 50 
µg ml-1 rifampicin and 40 µg ml-1 kanamycin for 
48 h at 18°C. The seed culture was used to 
inoculate 5 ml of LB medium containing 0.13 
mM of the various NBD-labeled phospholipids 
chemically synthesized in this study. The 
phospholipid solution in chloroform was dried 
in a sterilized tube with nitrogen gas, 
resolubilized in 80 µl of ethanol, and then 
hydrated with 5 ml of LB medium to a final 
concentration of 0.13 mM by vortexing. The 
cells were cultured at 6°C for 250 h until they 
reached stationary phase. 
Fluorescence microscopic analysis -- The 
culture (100 µl each) was sampled at 150, 200, 
and 250 h, and the fluorescence images were 
obtained using an epifluorescence microscope. 
For nuclei labeling, the cells collected at 250 h 
were treated with Hoechst 33342 (final 
concentration = 25 µg/ml) and washed twice 
with 200 µl of buffer A (0.75 M sucrose, 10 mM 
Tris-HCl (pH 7.5)). The fluorescence images 
were also obtained after dithionite treatment of 
the cells to quench the NBD fluorescence in the 
outer leaflet of the outer membrane. Further 
details are described in Supplemental Data. 
ESI-MS analysis of phospholipids -- After 
fluorescence microscopic analysis, lipids were 
extracted from the residual sample by the Bligh 
and Dyer method (24) and analyzed by 
electrospray ionization mass spectrometry 
(ESI-MS). Details of the ESI-MS analysis are 
described in Supplemental Data. 
Dithionite assay for measuring lipid 
distribution in the inner membrane (IM) and 
outer membrane (OM) -- To determine the 
distribution of NBD-labeled phospholipids in 
the IM and OM of the bacterium, we employed 
a fluorescence-quenching assay by using sodium 
dithionite. For this assay, the following three 
samples were prepared: non-treated, 
lysozyme-treated, and lysozyme-and-Triton 
X-100-treated cells (Fig. S1A). In the 
non-treated samples, only NBD-labeled 
phospholipids at the outer leaflet of the OM 
(OMout) are accessible by dithionite, and their 
fluorescence is quenched. In the 
lysozyme-treated samples, the OM is disrupted, 
and both the inner leaflet of the OM (OMin) and 
the outer leaflet of the IM (IMout), in addition to 
the OMout, become accessible to dithionite for 
fluorescence quenching. In the 
lysozyme-and-Triton X-100-treated samples, 
both OM and IM are disrupted, and the inner 
leaflet of the IM (IMin), as well as the OMout, 
OMin, and IMout, become accessible to dithionite. 
Further details of the dithionite assay are 
described in Supplemental Data. 
 
RESULTS 
Fate of fluorescence-labeled diacyl 
phospholipids in the cell membranes -- To 
visualize EPA-containing phospholipids in S. 
livingstonensis Ac10, we first synthesized a 
fluorescence-labeled phospholipid, 
N-NBD-1-oleoyl-2-eicosapentaenoyl-sn-glycero
-3-phosphoethanolamine (Diacyl-EPA) (Fig. 1 
and Supplemental Data for the synthesis). EPA 
was introduced into the sn-2 position because a 
polyunsaturated fatty acid is primarily found at 
this position in phospholipids in S. 
livingstonensis Ac10 and other organisms (25). 
The fluorescent NBD group was introduced into 
the head group to avoid modification of the 
hydrocarbon chain, which is to be characterized 
in the present study. As a control, we 
synthesized 
N-NBD-1,2-dioleoyl-sn-glycero-3-phosphoetha
nolamine (Diacyl-OLA), which contains the 
oleoyl group instead of the eicosapentaenoyl 
group at the sn-2 position (Fig. 1 and 
Supplemental Data for the synthesis). In these 
phospholipids, oleic acid (OLA, 18:19cis) was 
introduced into the sn-1 position, because OLA 
and OLA-containing phospholipids were shown 
to have neutral effects on the phenotype of the 
EPA-less mutant (13, 15). 
S. livingstonensis Ac10 was grown at 6°C 
in LB medium supplemented with Diacyl-EPA 
or Diacyl-OLA, and the cellular phospholipids 
were analyzed by ESI-MS. We found that the 
amounts of Diacyl-EPA and Diacyl-OLA in 
cellular membranes gradually decreased during 
cultivation for 166 h, while PEs and PGs 
containing EPA or OLA gradually increased 
(Fig. S2). The results suggest that Diacyl-EPA 
and Diacyl-OLA were hydrolyzed to yield free 
fatty acids, which were then incorporated into 
cellular PEs and PGs. Outer membrane 
phospholipase A likely catalyzed this hydrolysis 
(15, 26, 27). The NBD-moiety of Diacyl-EPA 
and Diacyl-OLA was not introduced into 
cellular phospholipids, as evaluated by ESI-MS 
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analysis. In accordance with the ESI-MS data, 
fluorescence microscopic analysis revealed that 
the Diacyl-EPA and Diacyl-OLA fluorescence 
was hardly detected at 150 h and thereafter (Fig. 
2). Thus, we learned that although EPA and 
OLA could be incorporated into the PE and PG, 
they could not be tracked visually because the 
fluorescent NBD-moiety was hydrolyzed and 
lost. Therefore, the NBD-labeled diacyl 
phospholipids are not suitable for continual 
visualization of EPA-containing phospholipids 
in vivo. 
Synthesis of fluorescent 
eicosapentaenyl-group-containing 
phospholipids -- For continual visualization of 
phospholipids in vivo, we synthesized 
NBD-containing hydrolysis-resistant PE 
derivatives to prevent the release of the 
hydrocarbon chain from the phospholipids. It is 
expected that replacement of the ester bond at 
the sn-2 position of phospholipids with an ether 
bond suppresses the hydrolytic release of the 
hydrocarbon chain from the glycerol backbone. 
Accordingly, we synthesized the following ether 







-phosphoethanolamine (Dialkyl-EPA), and 
N-NBD-1,2-dioleyl-sn-glycero-3-phosphoethan
olamine (Dialkyl-OLA) (Fig. 1 and 
Supplemental Data for the synthesis). 
Cellular uptake and remodeling of 
fluorescent eicosapentaenyl-group-containing 
phospholipids -- We tested whether these 
synthetic ether phospholipids are incorporated 
into the cell membrane of S. livingstonensis 
Ac10. The total lipids isolated from the cells 
grown in the presence of Acylalkyl-EPA, 
Acylalkyl-OLA, Dialkyl-EPA, or Dialkyl-OLA 
were analyzed by electrospray 
ionization-tandem mass spectrometry (Figs. 3 
and 4). NBD-labeled phospholipids were found 
in the cell membrane when any of the synthetic 
ether phospholipids were used (Fig. 3). We also 
found that Acylalkyl-EPA and Acylalkyl-OLA 
were hydrolyzed at the sn-1, but not sn-2, 
position to yield 
N-NBD-2-eicosapentaenyl-sn-glycero-3-phosph
oethanolamine (Lysoalkyl-EPA) and 
N-NBD-2-oleyl-sn-glycero-3-phosphoethanola
mine (Lysoalkyl-OLA), respectively, during 
cultivation (Fig. 4, white bars). In addition to 
Lysoalkyl-EPA and Lysoalkyl-OLA, re-acylated 
NBD-labeled phospholipids containing two 
hydrocarbon chains were produced at 200 and 
250 h (Fig. 4, black bars). The ratio of the total 
amount of the NBD-labeled phospholipids to the 
total amount of the unlabeled phospholipids in 
the cells grown in the presence of 
Acylalkyl-EPA for 250 h was 9.8 +/- 3.1%. The 
composition of the fatty acyl chains at the sn-1 
position of the NBD-labeled phospholipids 
derived from Acylalkyl-EPA is shown in Table 
1. These phospholipids, constituting 1%–5% of 
the total NBD-labeled phospholipids, were 
produced by the incorporation of a bacterial 
fatty acyl chain into the sn-1 position. In 
contrast to Acylalkyl-EPA and Acylalkyl-OLA, 
Dialkyl-EPA and Dialkyl-OLA were 
incorporated into the cell membrane without 
remodeling, because the ether bonds at the sn-1 
and sn-2 positions are both resistant to 
hydrolysis (Fig. 4). 
Distribution of NBD-labeled phospholipids 
in the IM and OM -- S. livingstonensis Ac10 is a 
Gram-negative bacterium, possessing both OM 
and IM. We measured the amount of 
NBD-labeled phospholipids distributed in these 
membranes by the dithionite quenching assay 
(see “Experimental Procedures” and 
“Supplemental Data” for details). To identify 
the membrane-specific location of the 
NBD-labeled phospholipids, we prepared the 
following three samples from cells grown at 6°C 
for 250 h: non-treated, lysozyme-treated, and 
lysozyme-and-Triton X-100-treated cells (Fig. 
S1A). By using these samples, NBD-labeled 
phospholipids located in the OMout, in the OMin 
and IMout, and in the IMin can be measured. Note 
that OMin and IMout cannot be distinguished by 
this assay. 
We calculated the ratio of the NBD 
fluorescence at the OMout, OMin+IMout, and IMin 
in the cells grown in the presence of 
Acylalkyl-EPA, Acylalkyl-OLA, Dialkyl-EPA, 
or Dialkyl-OLA for 250 h (Fig. 5). For 
Dialkyl-EPA and Dialkyl-OLA, the NBD 
fluorescence was found at the OMout and 
OMin+IMout, but almost no fluorescence was 
found at the IMin. In contrast, about 25% of the 
fluorescence was found at IMin when 
Acylalkyl-EPA or Acylalkyl-OLA was added to 
the cells. 
In these experiments, a large part of the 
NBD fluorescence was quenched even when 
non-treated cells were used. This is not due to 
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quenching of NBD-derivatives in the culture 
medium because the cells were washed well 
before dithionite treatment. The results rather 
indicate that a large part of the NBD-labeled 
phospholipids was localized in OMout. This 
uneven distribution between the different 
membrane surfaces is probably due to slow 
flip-flop of the lipids. 
Fluorescence microscopic analysis of the 
eicosapentaenyl-group-containing 
phospholipids -- We cultivated S. livingstonensis 
Ac10 at 6°C in LB medium containing the 
NBD-labeled ether phospholipids 
(Acylalkyl-EPA, Acylalkyl-OLA, Dialkyl-EPA, 
and Dialkyl-OLA) for fluorescence microscopic 
analysis. These cells showed more intense 
fluorescence than those grown in the presence of 
Diacyl-EPA or Diacyl-OLA, except for the cells 
grown in the presence of Dialkyl-OLA for 250 h 
(Fig. 2). The disappearance of the fluorescence 
from the cells grown in the presence of 
Dialkyl-OLA is probably due to degradation of 
the NBD-labeled phospholipids or their 
elimination from the cells (Fig. 3). We found 
that the fluorescence was localized at the center 
of the cells when they were grown in the 
presence of Acylalkyl-EPA for 200 h or longer, 
whereas this localization was not observed in 
cells grown in the presence of the control 
Acylalkyl-OLA (Figs. 2 and 6). Fluorescence 
localization was not observed also in the 
Dialkyl-EPA and Dialkyl-OLA experiment (Fig. 
2). 
To further characterize the fluorescence 
localization, the cellular nucleoids were stained 
with Hoechst 33342 in cells grown with 
Acylalkyl-EPA or Acylalkyl-OLA for 250 h. 
Each of the 15 randomly chosen cells 
undergoing cell division was divided into seven 
equally sized sections, and the fluorescence 
intensities of NBD and Hoechst 33342 in each 
segment were measured (Fig. 6B). We found 
that the NBD-labeled ether phospholipids were 
localized at the nucleoid occlusion site at the 
center of the Acylalkyl-EPA-treated cells 
undergoing cell division. This localization was 
not observed when Acylalkyl-OLA was used. 
On the other hand, the same localization as well 
as cellular uptake and remodeling were 
observed when the sn-1 oleoyl group of 
Acylalkyl-EPA was replaced by palmitoleoyl 
group (data not shown). Thus, the fluorescence 
localization at the center of the cells was 
dependent on the eicosapentaenyl-group of the 
phospholipid. The localization we observed in 
these experiments is in accordance with the 
physiological importance of EPA-containing 
phospholipids in cell division. 
Imaging of Lysoalkyl-EPA and its analog, 
N-NBD-1-methyl-2-eicosapentaenyl-sn-glycero-
3-phosphoethanolamine (Methylalkyl-EPA), in 
cell membranes -- As shown in Figs. 2 and 6, we 
found that NBD-phospholipids are localized at 
the center of the cells when Acylalkyl-EPA was 
added to the cells. Under this condition, some of 
the Acylalkyl-EPA added to the cells was 
converted into Lysoalkyl-EPA, which was 
subsequently re-acylated to form phospholipids 
with two hydrocarbon chains (Fig. 4). Thus, the 
fluorescent phospholipids localized at the center 
of the cells could be the Acylalkyl-EPA added 
to the cells, the converted Lysoalkyl-EPA, or the 
re-acylated phospholipids. To distinguish 
between these and examine whether 
Lysoalkyl-EPA produced from Acylalkyl-EPA 
was localized at the center of the cells, we 
synthesized a Lysoalkyl-EPA analog, 
Methylalkyl-EPA, for in vivo imaging (Fig. 1 
and Supplemental Data for the synthesis). 
Methylalkyl-EPA retains hydrophilicity of 
Lysoalkyl-EPA, which is considered important 
for the molecule to traverse through the 
periplasmic space to reach the IM. However, it 
is not susceptible to acylation at the sn-1 
position unlike Lysoalkyl-EPA. We also 
synthesized Lysoalkyl-EPA as a control (Fig. 1 
and Supplemental Data for the synthesis). 
S. livingstonensis Ac10 was grown in the 
presence of Lysoalkyl-EPA or Methylalkyl-EPA, 
and the cellular phospholipids were analyzed by 
ESI-MS. The amounts of NBD-labeled 
phospholipids found incorporated into the cells 
were not significantly different between 
Lysoalkyl-EPA and Methylalkyl-EPA (Fig. 3). 
We also determined the amounts of 
NBD-labeled phospholipids distributed to the 
OM and IM by the dithionite quenching assay 
(Fig. 5). NBD-labeled phospholipids were found 
not only in the OMout and OMin+IMout, but also 
in the IMin, irrespective of whether 
Lysoalkyl-EPA or Methylalkyl-EPA was used. 
Thus, Methylalkyl-EPA mimics Lysoalkyl-EPA 
in these respects. On the other hand, 
Methylalkyl-EPA is different from 
Lysoalkyl-EPA in that Methylalkyl-EPA was 
not acylated at the sn-1 position, as expected 
(Fig. 4). In the case of Lysoalkyl-EPA, the sn-1 
position was acylated, and the acyl chain 
composition at the sn-1 position was similar to 
that of the NBD-phospholipids derived from 
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Acylalkyl-EPA (Table 1). Fluorescence 
microscopic analysis revealed that the 
fluorescence localization at the center of the 
cells was observed when Lysoalkyl-EPA was 
added to the cells, whereas this localization was 
not observed when Methylalkyl-EPA was used 
(Fig. 6). This finding suggested that the 
localization at the center of the cells was 
dependent on the acylation of position sn-1. 
Fluorescence microscopic analysis of the 
cells treated with dithionite to quench the 
NBD-fluorescence in the OMout -- S. 
livingstonensis Ac10 was grown at 6°C for 250 
h in the presence of Acylalkyl-EPA or 
Lysoalkyl-EPA, and the NBD fluorescence in 
the OMout was quenched with sodium dithionite 
before fluorescence microscopic analysis as 
described in Experimental Procedures and 
Supplemental Data.  The relative fluorescence 
intensity at the cell division site was increased 
by the dithionite treatment of both 
Acylalkyl-EPA-labeled and 




Identity of the fluorescent phospholipid 
localized at the center of the cells during cell 
division -- We found that the NBD-labeled 
fluorescent phospholipids localized to the 
nucleoid occlusion site at the cell center during 
cell division when Acylalkyl-EPA was added to 
S. livingstonensis Ac10 (Figs. 2 and 6). This 
localization was 
eicosapentaenyl-group-dependent, because this 
localization was not observed when the cells 
were grown in the presence of Acylalkyl-OLA. 
Notably, when another phospholipid containing 
the eicosapentaenyl group was used, namely, 
Dialkyl-EPA, this localization was not observed 
(Fig. 2). This may be because of the difference 
in their subcellular distribution. The 
NBD-labeled phospholipids were detected in the 
IMin when Acylalkyl-EPA was used, whereas 
the NBD-labeled phospholipids were not found 
in the IMin with Dialkyl-EPA (Fig. 5). This was 
likely because the sn-1 position of Dialkyl-EPA 
was not hydrolyzed, rendering it less capable of 
migrating into the IMin. Because OMin and IMout 
cannot be distinguished by the dithionite 
quenching assay, it is possible that the 
NBD-labeled phospholipids did not even reach 
the IMout when Dialkyl-EPA was used. Thus, the 
data indicate that the NBD-labeled 
phospholipids that localize at the nucleoid 
occlusion site may come from the IM. This view 
is supported by the fluorescence microscopic 
analysis of the cells treated with dithionite. 
Dithionite treatment of the cells to quench the 
NBD fluorescence at the OMout increased 
relative fluorescence intensities at the cell 
division site (Fig. 7). 
When we used Diacyl-EPA, the cells were 
not labeled efficiently. This was probably due to 
the catalytic action of the OM phospholipase A 
(15, 26, 27); this enzyme likely catalyzed the 
cleavage of both ester-bonded hydrocarbon 
chains in Diacyl-EPA. Thus, the resulting 
fluorescent 
N-NBD-sn-glycero-3-phosphoethanolamine was 
likely released from the OM because of its high 
hydrophilicity and was not subsequently 
incorporated into any cellular membrane 
components, rendering it impossible for us to 
detect it by fluorescence methods. 
Acylalkyl-EPA was converted into 
Lysoalkyl-EPA (Fig. 4, white bars) and then 
re-acylated to form NBD-labeled phospholipids 
with two hydrocarbon chains, one of which was 
the eicosapentaenyl group and the other was an 
acyl group produced by the bacterial cells (Fig. 
4, black bars). Thus, the fluorescent 
phospholipids observed in our study that 
localized to the cell center could be 
Acylalkyl-EPA, Lysoalkyl-EPA, or re-acylated 
phospholipids. We found that the fluorescent 
phospholipids localized to the center of the cells 
when Lysoalkyl-EPA, but not Methylalkyl-EPA, 
was used (Fig. 6). Methylalkyl-EPA mimics 
Lysoalkyl-EPA in its distribution in the OM and 
IM but differs from Lysoalkyl-EPA in that it 
cannot be acylated at the sn-1 position. Thus, 
the results suggest that the fluorescence 
localization at nucleoid occlusion site was not 
due to Lysoalkyl-EPA itself but due to 
re-acylated phospholipids. In Gram-negative 
bacteria, 2-acylglycerolphosphoethanolamine 
acyltransferase, an enzyme that catalyzes the 
acylation of lysophospholipids at the sn-1 
position, is localized to the IM (28, 29). 
Considering that the NBD-labeled 
phospholipids were found in the IM when 
Lysoalkyl-EPA was added to the cells (Fig. 5), 
acylation of Lysoalkyl-EPA at the sn-1 position 
may have been catalyzed by this enzyme once it 
reached the IM; this allowed it to travel to the 
nucleoid occlusion site in the center of the 
bacterial cells. 
Dialkyl-EPA and Dialkyl-OLA did not 
reach the IMin (Fig. 5), suggesting that 
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phospholipids containing two hydrocarbon 
chains cannot traverse through the periplasmic 
space unless at least one of their hydrocarbon 
chains was cleaved off. The acyl group at the 
sn-1 position of Acylalkyl-EPA and 
Acylalkyl-OLA was probably hydrolyzed before 
they traversed through the periplasm to reach 
the IM. OM-resident phospholipase A most 
likely catalyzed this reaction to produce 
Lysoalkyl-EPA and Lysoalkyl-OLA, 
respectively (15, 26, 27). We consider that 
Lysoalkyl-EPA, produced by hydrolysis of 
Acylalkyl-EPA, is re-acylated at its sn-1 
position after reaching the IM, and the 
re-acylated NBD-labeled phospholipids are 
localized at the nucleoid occlusion site at the 
cell center during cell division. 
Mechanisms and significance of membrane 
microdomain formation enriched in 
polyunsaturated hydrocarbon chain-containing 
phospholipids -- We found that phospholipids 
containing an eicosapentaenyl group are 
enriched at the site of cell division. This is in 
accordance with our finding that 
EPA-containing phospholipids play an 
important functional role in the cell division in S. 
livingstonensis Ac10 (13). Although the 
molecular mechanism for the formation of the 
membrane domain enriched in polyunsaturated 
hydrocarbon chain remains unknown, we 
consider the following two possibilities. First, 
the phospholipids containing the 
eicosapentaenyl group are enriched in a 
membrane region with a high curvature because 
of their physicochemical properties. We 
consider this possibility because the bending 
rigidity of bilayers rich in phospholipids with a 
polyunsaturated hydrocarbon chain is known to 
be low (30). The cellular membrane at the site 
of cell division has a high curvature, which may 
cause the enrichment of phospholipids with the 
eicosapentaenyl group in this region. A second 
possibility is that phospholipids containing an 
eicosapentaenyl group interact with proteins 
localized at the center of the cells during cell 
division. Considering that EPA-containing 
phospholipids promote cell division, there may 
be a direct or indirect interaction between these 
phospholipids and cell-division-related proteins 
at the cell center. These interactions may cause 
enrichment of the 
eicosapentaenyl-group-containing phospholipids 
at the site of cell division. 
Polyunsaturated hydrocarbon chains have 
much greater diversity of energetically 
accessible conformational states than saturated 
hydrocarbon chains (31). This allows 
polyunsaturated hydrocarbon chains to solvate 
membrane proteins with rough surfaces with 
little energetic penalty. Thus, interaction with 
EPA-containing phospholipids may be 
beneficial for the stability and function of 
various membrane proteins, including those 
involved in cell division. The molecular 
interactions between EPA-containing 
phospholipids and membrane proteins involved 
in cell division are currently under investigation 
to better understand the role of EPA-containing 
phospholipids at the site of cell division. The 
occurrence of such membrane microdomains in 
other organisms and their specific physiological 
roles should also be examined in future studies. 
In the present study, the visualization of the 
membrane microdomain enriched in 
phospholipids with a polyunsaturated 
hydrocarbon chain was enabled by using a 
newly synthesized fluorescent probe with an 
uncleavable bond between the hydrocarbon 
chain and the glycerol backbone. This type of 
probe would be useful in examining whether 
membrane microdomains like the ones we 
observed in this study occur more generally 
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FIGURE 1. NBD-labeled phospholipids synthesized in this study. Diacyl-EPA, Diacyl-OLA, 
Acylalkyl-EPA, Acylalkyl-OLA, Dialkyl-EPA, and Dialkyl-OLA were named after the binding mode 
between the glycerol moiety and the hydrocarbon chains, as well as the hydrocarbon chain species at 
the sn-2 position. Acylalkyl-EPA, Acylalkyl-OLA, Dialkyl-EPA, Dialkyl-OLA, Methylalkyl-EPA, 
and Lysoalkyl-EPA correspond to the compounds 34, 33, 14, 21, 38, and 40, respectively, in Scheme 
S1 in Supplemental Data. 
 
FIGURE 2. Fluorescence microscopic images of S. livingstonensis Ac10 grown in the presence of 
NBD-labeled phospholipids (Diacyl-EPA, Diacyl-OLA, Acylalkyl-EPA, Acylalkyl-OLA, 
Dialkyl-EPA, and Dialkyl-OLA) for 150, 200, and 250 h. 
 
FIGURE 3. The amount of NBD-labeled phospholipids incorporated into the cells of S. 
livingstonensis Ac10 grown in the presence of Acylalkyl-EPA, Acylalkyl-OLA, Dialkyl-EPA, 
Dialkyl-OLA, Lysoalkyl-EPA, and Methylalkyl-EPA for 50 (white), 100 (light gray), 150 (dark gray), 
and 200 h (black). The amount was calculated as described in Experimental Procedures and 
Supplemental Data. The mean ± S.D. of three separate measurements is shown. 
 
FIGURE 4. Composition of NBD-labeled phospholipids in the cells of S. livingstonensis Ac10. The 
cells were grown in the presence of Acylalkyl-EPA, Acylalkyl-OLA, Dialkyl-EPA, Dialkyl-OLA, 
Lysoalkyl-EPA, and Methylalkyl-EPA for 100, 150, 200, and 250 h. Structures of NBD-labeled 
phospholipids extracted from the cells were analyzed by ESI-MS. The gray bars indicate externally 
added double-chain phospholipids. The white bars indicate single-chain phospholipids derived from 
Acylalkyl-EPA and Acylalkyl-OLA and externally added Lysoalkyl-EPA and Methylalkyl-EPA. The 
black bars indicate double-chain phospholipids produced in S. livingstonensis Ac10 by acylation of 
the sn-1 position of the single-chain phospholipids. The mean ± S.D. of three separate measurements 
is shown. 
 
FIGURE 5. The distribution of NBD-labeled phospholipids in the OMout (white), OMin + IMout (gray), 
and IMin (black). The cells were grown in the presence of the various NBD-labeled phospholipids 
indicated. The mean ± S.D. of three separate determinations is shown. 
 
FIGURE 6. Fluorescence microscopic images of S. livingstonensis Ac10 grown in the presence of 
NBD-labeled phospholipids. (A) Fluorescence microscopic images of the cells stained with Hoechst 
33342 (false-colored red) (left) and NBD-labeled phospholipids (center) and merged images (right). 
The cells were grown at 6°C for 250 h in the presence of NBD-labeled phospholipids indicated at the 
left. The scale bars correspond to 5 µm. (B) Quantification of subcellular localization of NBD-labeled 
phospholipids and Hoechst 33342. The cells were grown in the presence of Acylalkyl-EPA (I), 
Acylalkyl-OLA (II), Lysoalkyl-EPA (III), and Methylalkyl-EPA (IV) at 6°C for 250 h. In each case, 
15 cells during cell division were randomly chosen, and fluorescence intensities in seven equally 
sized sections of the cells (#1–#7) were determined by using ImageJ software. The closed symbols 
indicate the fluorescence of NBD-labeled phospholipids, and the open symbols indicate the 
fluorescence of Hoechst 33342. 
 
FIGURE 7. Fluorescence microscopic images of dithionite-treated S. livingstonensis Ac10 grown in 
the presence of NBD-labeled phospholipids. (A) Fluorescence microscopic images of the cells stained 
with Hoechst 33342 (false-colored red) (left) and NBD-labeled phospholipids (center) and merged 
images (right). The cells were grown at 6°C for 250 h in the presence of Acylalkyl-EPA or 
Lysoalkyl-EPA as indicated at the left. For each of the Acylalkyl-EPA-labeled and 
Lysoalkyl-EPA-labeled cells, fluorescence images with (upper) or without (lower) treatment of 
dithionite are shown. The scale bars correspond to 5 µm. (B) Quantification of subcellular localization 
of NBD-labeled phospholipids and Hoechst 33342. The cells were grown in the presence of 
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Acylalkyl-EPA (I) and Lysoalkyl-EPA (II) at 6°C for 250 h. In each case, 15 cells during cell division 
were randomly chosen, and fluorescence intensities in seven equally sized sections of the cells 
(#1–#7) were determined by using ImageJ software. The closed symbols indicate the fluorescence of 
NBD-labeled phospholipids, and the open symbols indicate the fluorescence of Hoechst 33342. The 
dotted and solid lines indicate fluorescence intensities of the cells with and without treatment with 
dithionite, respectively. 
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Table 1. Composition of the sn-1 acyl chain of NBD-phospholipids from the cells cultivated with 
Acylalkyl-EPA and Lysoalkyl-EPA. 
 
sn-1 acyl chain 
Relative amount (%) 
Acylalkyl-EPA Lysoalkyl-EPA 
13:0 4.0 ± 0.3 4.1 ± 0.6 
13:1 1.2 ± 0.6 1.6 ± 0.6 
14:0 4.0 ± 2.6 4.7 ± 2.6 
14:1 1.6 ± 1.0 1.8 ± 1.0 
15:0 19.0 ± 9.2 24.5 ± 12.3 
15:1 0.9 ± 0.2 1.3 ± 0.6 
16:0 0.7 ± 0.1 1.0 ± 0.2 
16:1 29.6 ± 6.4 37.2 ± 11.4 
17:0 6.6 ± 0.6 8.2 ± 0.7 
17:1 3.3 ± 0.5 4.1 ± 0.2 
18:0 2.1 ± 0.4 2.7 ± 0.6 
18:1 27.0 ± 2.1 8.8 ± 1.1 
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Occurrence of Bacterial Membrane Microdomain at the Cell Division Site 
Enriched in Phospholipids with Polyunsaturated Hydrocarbon Chain 
Sho Sato, Jun Kawamoto, Satoshi B. Sato, Bunta Watanabe, Jun Hiratake, 
Nobuyoshi Esaki, and Tatsuo Kurihara 
 
Supplementary Experimental Procedures 
 
Synthesis of fluorescent probes 
Unless otherwise specified, materials were obtained from commercial 
suppliers––Sigma-Aldrich Co., Tokyo Chemical Industry Co., Ltd., and Wako Pure Chemical 
Industries, Ltd.––at the highest level of purity available and were used without further 
purification. Dry solvents were purchased from Wako Pure Chemical Industries, Ltd., and 
used in the form supplied. Flash chromatography was carried out using silica gel 60N 
(spherical and neutral, particle diameter: 40–50 µm; Kanto Chemical Co., Inc.). Thin-layer 
chromatography (TLC) was performed on glass-backed precoated silica gel plates (Merck 
silica gel 60 F254 and 60). Spots were detected with a UV hand lamp at 254 nm or by staining 
with either iodine vapor or 0.65% (w/v) molybdate dissolved in H2SO4/H2O (10:90 v/v). 
Synthesized compounds were characterized by NMR (1H and, if appropriate, 31P) and/or MS. 
NMR spectra were recorded using a Bruker UltraShieldTM Advance 400 (400 MHz, 1H; 160 
MHz, 31P) spectrometer or JEOL JNM-AL-300 (300 MHz, 1H) FT NMR system spectrometer. 
The instrument was calibrated using residual undeuterated solvent and tetramethylsilane as 
internal references. Mass spectra were recorded by electrospray ionization mass spectrometry 
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(ESI-MS) with an Applied Biosystems API3000 LC/MS/MS system. 
Diacyl-EPA and Diacyl-OLA were synthesized by introducing the NBD group into 
phosphatidylethanolamine containing EPA (OEPE) and OLA (DOPE), respectively, by the 
same method described for compound 14. OEPE and DOPE were synthesized as described 
previously (1). The synthetic route for other fluorescent probes used in this study is 




To a magnetically stirred mixture of oleic acid (1, 2.51 g, 8.90 mmol) in 40 ml dry 
tetrahydrofuran (THF) on ice was added LiAlH4 (1.01 g, 26.7 mmol) by bits. The reaction 
mixture was stirred at room temperature for 1 h and then cooled on ice. Excess LiAlH4 was 
quenched with 1 ml of water and 4 ml of 10% (w/v) aqueous NaOH solution, and the mixture 
was dried over magnesium sulfate. The mixture was then suction-filtered, and the filtrate was 
evaporated to afford the crude product (2.49 g) as a colorless oil, which was used for the 
subsequent synthesis without further purification. Rf = 0.15 (benzene). 1H-NMR (300 MHz, 
CDCl3): δ 5.42-5.28 (m, 2H), 3.64 (dt, 2H, J = 5.4 and 5.4), 2.12-1.96 (m, 4H), 1.57 (tt, 2H, J 
= 7.2 and 7.2), 1.43-1.19 (m, 22H), 0.89 (t, 3H, J = 6.9). 
 
Compound 4 
Using a procedure similar to that described for the preparation of 3, crude 
compound 4 (0.826 g) was obtained from EPA (0.765 g, 2.53 mmol). Rf = 0.15 (benzene). 
1H-NMR (300 MHz, CDCl3): δ 5.62-5.27 (m, 10H), 3.65 (dt, J = 6.0 and 6.0, 2H), 2.92-2.74 
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(m, 8H), 2.18-2.02 (m, 4H), 1.62-1.52 (m, 2H), 1.51-1.39 (m, 2H), 0.98 (t, 3H, J = 7.4). 
 
Compound 5 
 Compound 3 (2.35 g, 8.75 mmol) and triethylamine (2.70 g, 26.7 mmol) were 
dissolved in 30 ml of dry benzene at room temperature under a nitrogen atmosphere. To this 
solution was added methanesulfonyl chloride (3.06 g, 26.7 mmol). After stirring for 2 h, the 
reaction mixture was suction-filtered, and subsequent removal of solvent of the filtrate under 
reduced pressure afforded a crude product, which was purified by flash column 
chromatography (eluted with hexane/ethyl acetate = 95:5 to 80:20) to yield compound 5 (2.45 
g, 7.07 mmol) as a colorless oil. Rf = 0.35 (benzene). 1H-NMR (300 MHz, CDCl3): δ 
5.45-5.30 (m, 2H), 4.22 (t, 2H, J = 6.0), 3.01 (s, 3H), 2.08-1.96 (m, 4H), 1.75 (tt, 2H, J = 6.8 
and 6.8), 1.60-1.10 (m, 22H), 0.89 (t, 3H, J = 7.5). 
 
Compound 6 
Using a procedure similar to that described for the preparation of 5, compound 6 
(1.13 g, 3.08 mmol, 93%) was obtained. Rf = 0.35 (benzene). 1H-NMR (300 MHz, CDCl3): δ 
5.46-5.26 (m, 10H), 4.23 (t, 2H, J = 6.5), 3.00 (s, 3H), 2.88-2.75 (m, 8H), 2.16-2.03 (m, 4H), 
1.83-1.70 (m, 2H), 1.54-1.44 (m, 2H), 0.98 (t, 3H, J = 7.4). 
 
Compound 8 
 To a magnetically stirred mixture of NaH (0.136 g, 3.41 mmol) in 5 ml dry DMSO 
at room temperature was added (R)-(2,2-dimethyl-1,3-dioxolan-4-yl)methanol (7, 0.300 g, 
2.27 mmol) of  dissolved in 5 ml dry DMSO dropwise. To the resulting solution, compound 5 
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(0.866 g, 2.50 mmol) dissolved in 10 ml dry DMSO was slowly added, and the reaction 
mixture was stirred for 20 h. The reaction mixture was then poured into water (250 ml) and 
extracted with hexane (250 ml). The combined organic layers were concentrated under 
reduced pressure to obtain compound 8 (0.578 g, 1.51 mmol, 67%), which was used for the 
subsequent synthesis without further purification. Rf = 0.54 (hexane/ethyl acetate = 9:1). 
1H-NMR (300 MHz, CDCl3): δ 5.40-5.28 (m, 2H), 4.26 (tt, 1H, J = 5.6 and 5.6), 4.06 (dd, 1H, 
J = 8.1 and 6.6), 3.73 (dd, 1H, J = 8.3 and 6.5), 3.54-3.37 (m, 4H), 2.06-1.94 (m, 4H), 
1.60-1.56 (tt, 2H, J = 6.0 and 6.0), 1.42 (s, 3H), 1.36 (s, 3H), 1.24-1.34 (m, 22H), 0.82-0.85 (t, 
3H, J = 7.2). 
 
Compound 9 
Compound 8 (0.578 g, 1.51 mmol) was dissolved in dry CHCl3 (15 ml) at room 
temperature under a nitrogen atmosphere. To the mixture was added 0.5 N HCl in 15 ml 
methanol. After stirring for 1 h, subsequent removal of the solvent under reduced pressure 
afforded 9  (0.535 g, 1.51 mmol, 100%), which was used for the subsequent synthesis without 
further purification. Rf = 0.07 (hexane/ethyl acetate = 3:2). 
 
Compound 10 
 Compound 9 (0.535 g, 1.51 mmol) and diisopropylethylamine (0.293 g, 2.27 mmol) 
were dissolved in 3.1 ml of dry dichloromethane at room temperature under a nitrogen 
atmosphere. To this solution was added triphenylmethyl chloride (0.462 g, 1.66 mmol). After 
stirring for 14 h, the reaction mixture was concentrated under reduced pressure to afford a 
crude product, which was purified by flash column chromatography (eluted with hexane/ 
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ethyl acetate = 98:2 to 95:5) to yield compound 10 (0.861 g, 1.47 mmol, 97%) as a colorless 
oil. Rf = 0.31 (hexane/ethyl acetate = 9:1). 1H-NMR (300 MHz, CDCl3): δ 7.48-7.22 (m, 15H), 
5.35-5.29 (m, 2H), 3.95-3.91 (m, 1H), 3.56-3.40 (m, 4H), 3.21 (dd, 1H, J = 9.3 and 5.7), 3.17 
(dd, 1H, J = 9.3 and 5.4), 2.40 (d, 1H, J = 4.8), 2.04-1.98 (m, 4H), 1.59-1.49 (m, 2H), 
1.39-1.32 (m, 22H), 0.88 (t, 3H, J = 6.9). 
 
Compound 11 
Compound 10 (0.585 g, 1.00 mmol) and powdered KOH (0.272 g, 4.12 mmol) were 
dissolved in dry benzene (21 ml) at room temperature under a nitrogen atmosphere. 
Compound 6 (0.367 g, 1.00 mmol) dissolved in 6 ml dry benzene was slowly added to the 
resulting solution, and the reaction mixture was stirred for 2 h at 40˚C. The mixture was 
poured into water, and the product was extracted with hexane. After the solvent was removed 
under the reduced pressure, the crude product was purified by flash column chromatography 
(eluted with hexane/ethyl acetate = 99:1 to 98:2) to yield compound 11 (0.235 g, 0.275 mmol, 
28%) as a colorless oil. Rf = 0.63 (hexane/ethyl acetate = 4:1). 1H-NMR (300 MHz, CDCl3): δ 
7.48-7.22 (m, 15H), 5.42-5.29 (m, 12H), 3.60-3.35 (m, 7H), 3.25-3.15 (m, 2H), 2.87-2.75 (m, 
8H), 2.12-1.95 (m, 8H), 1.65-1.40 (m, 6H), 1.39-1.21 (m, 22H), 0.97 (t, 3H, J = 7.7), 0.88 (t, 
3H, J = 6.6). 
 
Compound 12  
Compound 11 (0.334 g, 0.457 mmol) was dissolved in dry CHCl3 (25 ml) at room 
temperature under a nitrogen atmosphere. To the mixture was added 0.5 N HCl in 25 ml 
methanol. After stirring for 1 h, subsequent removal of the solvent under reduced pressure 
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afforded the crude product, which was purified by flash column chromatography (eluted with 
hexane/ethyl acetate = 97:3 to 9:1) to yield compound 12 (0.176 g, 0.287 mmol, 63%) as a 
colorless oil. Rf = 0.26 (hexane/ethyl acetate = 4:1). 1H-NMR (300 MHz, CDCl3): δ 5.45-5.25 
(m, 12H), 3.78-3.68 (m, 1H), 3.67-3.48 (m, 6H), 3.48-3.38 (t, 2H, J = 6.6), 2.85-2.75 (m, 8H), 
2.18-1.90 (m, 8H), 1.63-1.56 (m, 4H), 1.43 (tt, 2H, J = 7.7 and 7.7), 1.32-1.26 (m, 22H), 0.98 
(t, 3H, J = 7.7), 0.88 (t, 3H, J = 6.6). 
 
Compound 13 
 Phosphorous oxychloride (65.9 mg, 0.431 mmol) was dissolved in 0.45 ml of 
hexane and stirred at 5˚C. After the addition of triethylamine (43.5 mg, 0.431 mmol) 
dissolved in 0.9 ml of trichloroethylene, stirring was continued, and a solution of compound 
12 (0.176 g, 0.287 mmol) in 3.5 ml of trichloroethylene was added dropwise over 30 min. 
After 1 h, the reaction mixture was filtered. Then 1 ml of toluene was added to the filtrate, 
and removed under the reduced pressure to afford the crude oil. To a magnetically stirred 
solution of the crude oil and triethylamine (116 mg, 1.15 mmol) in 4.3 ml of dry THF at 0˚C 
was added a solution of 2-aminoethanol (21.9 mg, 0.359 mmol) in 0.5 ml of dry THF. Then, 
the mixture was warmed to room temperature and kept stirring for 30 min. After an additional 
30 min, the reaction mixture was suction-filtered. The filtrate solvent was removed under the 
reduced pressure to give the white crude oil. To a solution of the white crude oil in 5.7 ml of 
2-propanol was added 2.9 ml of acetic acid/water (1:4), and then the reaction mixture was 
stirred magnetically for 2 h. The mixture was poured into 30 ml of 
chloroform/methanol/water (1:1:0.9), and the lower layer was collected and evaporated to 
afford the white solid, which was purified by flash column chromatography (eluted with 
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chloroform/methanol = 8:2 to 7:3) to yield compound 13 (0.187 g, 0.254 mmol, 89%) as a 
white solid. Rf = 0.44 (chloroform/methanol/28% NH3 solution = 65:25:4). 1H-NMR (400 
MHz, CDCl3): δ 8.68-8.42 (br s, 2H), 5.48-5.26 (m, 12H), 4.15-4.04 (br s, 2H), 3.91 (dd, 1H, 
J = 9.2 and 5.3), 3.87 (dd, 1H, J = 9.3 and 5.3), 3.63-3.35 (m, 7H), 3.23-3.05 (br s, 2H), 
2.88-2.76 (m, 8H), 2.12-1.97 (m, 8H), 1.62-1.48 (m, 4H), 1.40 (m, 2H), 1.35-1.20 (m, 22H), 
0.97 (t, 3H, J = 7.6), 0.88 (t, 3H, J = 7.0). 31P-NMR (160 MHz, CDCl3): δ 0.960. ESI-MS: 
734.6 [M-H]- (C43H78O6PN). 
 
Compound 14 
 Into a brown-colored flask was placed a chloroform solution (3.5 ml) of compound 
13 (36.8 mg, 0.050 mmol), 4-fluoro-7-nitrobenzofurazan (NBD-F) (Dojindo Laboratories, 
Kumamoto, Japan) (30.2 mg, 0.165 mmol), and triethylamine (17.2 mg, 0.170 mmol) under a 
nitrogen atmosphere. The mixture was stirred at room temperature for 1 h and subsequent 
removal of solvent under reduced pressure afforded a crude product, which was purified by 
flash column chromatography (eluted with benzene/methanol = 9:1) to yield 36.9 mg of 
compound 14 (36.9 mg, 0.041 mmol, 82 %). Rf = 0.73 (chloroform/methanol/28 % NH3 
solution = 65:25:4). ESI-MS: 897.6 [M-H]-. (C49H79O9PN4). 
 
Compound 16 
 To a stirred mixture of NaH (1.09 g, 25.2 mmol) in dry THF (38 ml) was added 
dropwise (S)-(2,2-dimethyl-1,3-dioxolan-4-yl)methanol (15, 2.50 g, 18.9 mmol) at 0˚C. After 
it was stirred at room temperature for 30 min and then cooled on ice, p-methoxybenzyl 
chloride (2.96 g, 18.9 mmol) was slowly added to the resulting solution. After refluxing at 
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70˚C overnight, the solvent was removed under reduced pressure. The residue was 
redissolved in hexane and suction-filtered. To the filtrate washed with the same volume of 
water twice was added magnesium sulfate followed by the second suction-filtration. 
Subsequent removal of the solvent under reduced pressure afforded the crude product 16, 
which was used for the subsequent synthesis without further purification. Rf = 0.41 
(hexane/ethyl acetate = 4:1). 1H-NMR (300 MHz, CDCl3): δ 7.26 (d, 2H, J = 8.4), 6.88 (d, 2H, 
J = 8.4), 4.52 and 4.49 (d, 1H, J = 9.9), 4.28 (tt, 1H, J = 6.3 and 6.3), 4.04 and 3.72  (dd, 1H, J 
= 8.3 and 6.3), 3.80 (s, 3H), 3.53 and 3.44 (dd, 1H, J = 9.7 and 5.4), 1.42 and 1.36 (s, 3H). 
 
Compound 17 
 To a magnetically stirred mixture of 16 (5.79 g, 22.9 mmol) dissolved in dry THF 
(45 ml) on ice was added dropwise 1 N HCl aqueous solution (45 ml). After stirring at room 
temperature for 10 h, 5 N NaOH aqueous solution was gently added to adjust to pH 8 on ice. 
The mixture was poured into saturated NaCl aqueous solution, and the product was extracted 
with ethyl acetate. After the solvent was removed under the reduced pressure, the crude 
product was purified by flash column chromatography (eluted with chloroform/methanol = 
90:10 to 85:15) to yield compound 17 (4.52 g, 21.3 mmol, 93%) as a colorless oil. Rf = 0.13 
(hexane/ethyl acetate = 3:2). 1H-NMR (300 MHz, CDCl3): δ 7.25 (d, 2H, J = 7.8), 6.89 (d, 2H, 
J = 8.7), 4.48 (s, 2H), 3.86 (tt, 1H, J = 5.0 and 5.0), 3.81 (s, 3H), 3.73-3.48 (m, 4H), 2.67 (d, 
1H, J = 5.1), 2.20 (dd, 1H, J = 6.6 and 5.7). 
 
Compound 18 
Compound 17 (0.213 g, 1.00 mmol), NaH (0.159 g, 4.00 mmol), and dry DMSO 
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(15 ml) were placed in a round-bottomed flask under a nitrogen atmosphere. Compound 5 
(0.693 g, 2.00 mmol) dissolved in 2 ml of dry DMSO was then added, and the reaction 
mixture was stirred at room temperature for 24 h. To the reaction mixture was added water. 
The mixture was then extracted with ethyl acetate. After the combined organic layers were 
concentrated under reduced pressure, the crude product was purified by flash column 
chromatography (eluted with hexane/ethyl acetate = 97:3 to 95:5) to give compound 18 (0.320 
g, 0.449 mmol, 45%) as a colorless oil. Rf = 0.33 (benzene). 1H-NMR (300 MHz, CDCl3): δ 
7.25 (d, 2H, J = 8.7), 6.87 (d, 2H, J = 8.7), 5.40-5.29 (m, 4H), 4.48 (s, 2H), 3.80 (s, 3H), 




 Compound 18 (71.3 mg, 0.100 mmol) was dissolved in a mixture of 10 ml of 
dichloromethane and 133 µl of 0.1-M phosphate buffer solution (pH 7.2), and the resulting 
solution was stirred at 0˚C for 1 h. To the resulting solution was added of 
2,3-dichloro-5,6-dicyano-p-benzoquinone (DDQ, 45.4 mg, 0.200 mmol), followed by 
additional stirring at room temperature for 2 h. The mixture was extracted with ethyl acetate. 
The solvent of the combined organic layers was then removed under reduced pressure. The 
resulting crude product was purified by flash column chromatography (hexane/ethyl acetate =  
95:5), yielding compound 19 (45.2 mg, 76.1 µmol, 76%) as a colorless oil. Rf = 0.52 
(hexane/ethyl acetate = 4:1). 1H-NMR (300 MHz, CDCl3): δ 5.40-5.30 (m, 4H), 3.77-3.67 (m, 
1H), 3.66-3.35 (m, 8H), 2.01 (dd, 8H, J = 5.4 and 5.4), 1.62-1.52 (m, 4H), 1.40-1.20 (m, 44H), 




 Using a procedure similar to that described for the preparation of 13, compound 20 
(23.1 mg, 32.3 µmol, 19%) was obtained. Rf = 0.44 (chloroform/methanol/28% NH3 solution 
= 65:25:4). 1H-NMR (400 MHz, CDCl3): δ 8.68-8.42 (br s, 2H), 5.48-5.26 (m, 4H), 4.15-4.04 
(br s, 2H), 3.91 (dd, 1H, J = 9.2 and 5.3), 3.87 (dd, 1H, J = 9.3 and 5.3), 3.63-3.35 (m, 7H), 
3.23-3.05 (br s, 2H), 2.12-1.97 (m, 8H), 1.62-1.48 (m, 4H), 1.35-1.20 (m, 44H), 0.88 (t, 6H, J 
= 7.0). 31P-NMR (160 MHz, CDCl3): δ 0.961. ESI-MS: 714.6 [M-H]- (C41H82O6PN). 
 
Compound 21 
 Using a procedure similar to that described for the preparation of 14, compound 21 
(6.1 mg, 6.94 µmol, 69%) was obtained. Rf = 0.35 (benzene). Rf = 0.44 




 Compound 17 (1.26 g, 5.95 mmol) and diisopropylethylamine (1.15 g, 8.93 mmol) 
were dissolved in 13 ml of dry dichloromethane at room temperature under nitrogen 
atmosphere. To this solution was added triphenylmethyl chloride (1.83 g, 6.54 mmol). After 
stirring overnight, the reaction mixture was concentrated under reduced pressure. The residue 
was redissolved in benzene and purified by flash column chromatography (eluted with 
benzene/methanol = 98:2 to 9:1) to yield compound 22 (2.61 g, 5.72 mmol, 96%). Rf = 0.23 
(hexane/ethyl acetate = 4:1).  1H-NMR (300 MHz, CDCl3): δ 7.45-7.18 (m, 17H), 6.86 (d, 2H, 
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J = 8.4), 4.46 (s, 2H), 3.96 (tt, 1H, J = 5.3 and 5.3), 3.80 (s, 3H), 3.57 (dd, 1H, J = 9.5 and 
4.3), 3.52 (dd, 1H, J = 9.5 and 6.6), 3.22 (dd, 1H, J = 9.0 and 5.7), 3.18 (dd, 1H, J = 8.9 and 
5.0), 2.39 (d, 1H, J = 4.8). 
 
Compound 23 
Compound 22 (1.36 g, 3.00 mmol), NaH (0.263 g, 6.57 mmol), and dry DMSO (22 
ml) were placed in a round-bottomed flask under a nitrogen atmosphere. Compound 5 (0.520 
g, 1.5 mmol) dissolved in 3 ml of dry DMSO was then added, and the reaction mixture was 
stirred at room temperature for 5 h. To the reaction mixture was added water. The mixture 
was then extracted with hexane. After the combined organic layers were concentrated under 
reduced pressure, the crude product was purified by flash column chromatography (eluted 
with hexane/ethyl acetate = 98:2 to 9:1) to give compound 23 (0.688 g, 0.977 mmol, 65%) as 
a colorless oil. Rf = 0.56 (benzene). 1H-NMR (300 MHz, CDCl3): δ 7.47-7.41 (m, 6H), 
7.32-7.15 (m, 11H), 6.83 (d, 2H, J = 8.7), 5.41-5.27 (m, 2H), 4.46 and 4.42 (d, 1H, J = 12.0), 
2.93 (s, 3H), 3.62-3.47 (m, 5H), 3.19 (d, 2H, J = 4.2), 2.00 (m, 4H), 1.56 (tt, 2H, J = 6.9 and 
6.9), 1.38-1.20 (m, 22H), 0.88 (t, 3H, J = 6.6). 
 
Compound 24 
 Compound 22 (0.326 g, 0.718 mmol) and powdered KOH (0.201 g, 3.05 mmol) 
were dissolved in dry benzene (15 ml) at room temperature under a nitrogen atmosphere. 
Compound 6 (0.263 g, 0.718 mmol) dissolved in 2 ml dry benzene was slowly added to the 
resulting solution, and the reaction mixture was stirred for 12 h at 40˚C. The mixture was 
poured into water, and the product was extracted with hexane. After the solvent was removed 
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in vacuo, the crude product was purified by flash column chromatography (eluted with 
hexane/ethyl acetate = 97:3 to 95:5) to yield compound 24 (0.216 g, 0.303 mmol, 42%) as a 
colorless oil. Rf = 0.63 (hexane/ethyl acetate = 4:1). 1H-NMR (300 MHz, CDCl3): δ 7.36-7.18 
(m, 6H), 7.17-7.07 (m, 11H), 6.83 (d, 2H, J = 8.4), 5.44-5.29 (m, 10H), 4.45 and 4.42 (d, 1H, 
J = 12.0), 3.79 (s, 3H), 3.63-3.50 (m, 5H), 3.19 (d, 2H, J = 3.9), 2.88-2.78 (m, 8H), 2.14-2.02 
(m, 4H), 1.64-1.55 (m, 2H), 1.43 (tt, 2H, J = 7.1 and 7.1), 0.97 (t, 3H, J = 7.5). 
 
Compound 25 
 Compound 23 (0.678 g, 0.961 mmol) was dissolved in dry CHCl3 (75 ml) at room 
temperature under a nitrogen atmosphere. To the mixture was added 0.5 N HCl in 75 ml 
methanol. After stirring for 1 h, subsequent removal of the solvent under reduced pressure 
afforded the crude product, which was purified by flash column chromatography (eluted with 
hexane/ethyl acetate = 9:1 to 8:2) to yield compound 25 (0.317 g, 0.703 mmol, 73%) as a 
colorless oil. Rf = 0.26 (hexane/ethyl acetate = 4:1). 1H-NMR (300 MHz, CDCl3): δ 7.25 (d, 
2H, J = 8.1), 6.88 (d, 2H, J = 8.4), 5.40-5.29 (m, 2H), 4.47 (s, 2H), 3.80 (s, 3H), 3.75-3.46 (m, 
7H), 2.13-1.95 (m, 4H), 1.63-1.51 (m, 2H), 1.45-1.20 (m, 22H), 0.88 (t, 3H, J = 6.6). 
 
Compound 26 
 Using a procedure similar to that described for the preparation of 25, compound 26 
(137 mg, 0.291 mmol, 91%) was obtained. Rf = 0.26 (hexane/ethyl acetate = 4:1). 1H-NMR 
(300 MHz, CDCl3): δ 7.25 (d, 2H, J = 8.4), 6.88 (d, 2H, J = 8.7), 5.48-5.25 (m, 10H), 4.47 (s, 
2H), 3.80 (s, 3H), 3.75-3.46 (m, 7H), 2.92-2.76 (m, 8H), 2.16-2.00 (m, 4H), 1.66-1.50 (m, 




 To a magnetically stirred mixture of 25 (105 mg, 0.228 mmol), 
dicyclohexylcarbodiimide (127 mg, 0.616 mmol), and dimethylaminopyridine (40.1 mg, 
0.296 mmol) dissolved in 4.5 ml of dry chloroform was added oleic acid (142 mg, 0.502 
mmol) under a nitrogen atmosphere at 0˚C. Subsequent removal of the solvent under reduced 
pressure after stirring for 11 h at room temperature afforded the crude product, which was 
purified by flash column chromatography (eluted with a mixture of hexane and ethyl acetate 
(98/2 to 95/5, v/v)) to yield compound 27 (156 mg, 0.220 mmol, 94%) as a colorless oil. Rf = 
0.70 (hexane/ethyl acetate = 4:1). 1H-NMR (300 MHz, CDCl3): δ 7.25 (d, 2H, J = 8.7), 6.87 
(d, 2H, J = 8.4), 5.41-5.26 (m, 4H), 4.48 (s, 2H), 4.23 (dd, 1H, J = 11.7 and 4.2), 4.11 (dd, 1H, 
J = 11.7 and 5.7), 3.80 (s, 3H), 3.64 (tt, 1H, J = 5.4 and 5.4), 3.58-3.46 (m, 4H), 2.29 (t, 2H, J 
= 7.5), 2.08-1.94 (m, 8H), 1.68-1.48 (m, 4H), 1.39-1.22 (m, 42H), 0.88 (t, 6H, J = 6.6). 
 
Compound 28 
 Using a procedure similar to that described for the preparation of 27, compound 28 
(143 mg, 0.192 mmol, 95%) was obtained. Rf = 0.53 (hexane/ethyl acetate = 4:1). 1H-NMR 
(300 MHz, CDCl3): δ 7.25 (d, 2H, J = 8.7), 6.87 (d, 2H, J = 8.4), 5.46-5.28 (m, 12H), 4.47 (s, 
2H), 4.23 (dd, 1H, J = 11.6 and 4.4), 4.11 (dd, 1H, J = 11.4 and 5.7), 3.80 (s, 3H), 3.64 (tt, 1H, 
J = 5.0 and 5.0), 3.58-3.47 (m, 4H), 2.90-2.76 (m, 8H), 2.29 (t, 2H, J = 7.5), 2.14-1.96 (m, 





 Using a procedure similar to that described for the preparation of 19, compound 29 
(136.5 mg, 0.226 mmol, 56%) was obtained. Rf = 0.37 (hexane/ethyl acetate = 4:1). 1H-NMR 
(300 MHz, CDCl3): δ 5.44-5.28 (m, 4H), 4.26-4.12 (m, 2H), 3.74-3.46 (m, 5H), 2.32 (t, 2H, J 
= 7.5), 2.08-1.94 (m, 8H), 1.72-1.52 (m, 4H), 1.42-1.22 (m, 42H), 0.88 (t, 6H, J = 6.6). 
 
Compound 30 
 Using a procedure similar to that described for the preparation of 19, compound 30 
(60.0 mg, 95.7 µmol, 48%) was obtained. Rf = 0.33 (hexane/ethyl acetate = 4:1). 1H-NMR 
(300 MHz, CDCl3): δ 5.38-5.21 (m, 12H), 4.10 (dd, 2H, J = 4.2 and 2.4), 3.65-3.41 (m, 5H), 
2.78 (t, 4H, J = 4.8), 2.75 (t, 4H, J = 5.4), 2.29 (t, 2H, J = 7.5), 2.14-1.88 (m, 8H), 1.62-1.46 
(m, 4H), 1.36 (m, 2H), 1.36-1.10 (m, 20H), 0.91 (t, 3H, J = 7.5), 0.81 (t, 3H, J = 6.6). 
 
Compound 31 
 Using a procedure similar to that described for the preparation of 13, compound 31 
(60.0 mg, 0.124 mmol, 75%) was obtained. Rf = 0.44 (chloroform/methanol/28% NH3 
solution = 65:25:4). 1H-NMR (400 MHz, CDCl3): δ 8.68-8.42 (br s, 2H), 5.45-5.28 (m, 4H), 
4.28 (dd, 2H, J = 8.9 and 2.6), 4.15-4.04 (br s, 2H), 3.96-3.81 (br s, 2H), 3.64-3.48 (m, 3H), 
3.19-3.12 (br s, 2H), 2.30 (t, 2H, J = 5.7), 2.12-1.97 (m, 8H), 1.62-1.50 (m, 4H), 1.36-1.20 (m, 
42H), 0.88 (t, 6H, J = 5.3). 31P-NMR (160 MHz, CDCl3): δ 0.998. 
 
Compound 32 
 Using a procedure similar to that described for the preparation of 13, compound 32 
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(22.0 mg, 29.3 µmol, 30%) was obtained. Rf = 0.44 (chloroform/methanol/28% NH3 solution 
= 65:25:4). 1H-NMR (400 MHz, CDCl3): δ 8.68-8.42 (br s, 2H), 5.48-5.25 (m, 12H), 4.28 (dd, 
2H, J = 8.9 and 2.6), 4.15-4.04 (br s, 2H), 3.96-3.81 (br s, 2H), 3.64-3.48 (m, 3H), 3.19-3.12 
(br s, 2H), 2.88-2.76 (m, 8H), 2.30 (t, 2H, J = 5.7), 2.12-1.97 (m, 8H), 1.62-1.50 (m, 4H), 1.40 
(m, 2H), 1.36-1.20 (m, 20H), 0.97 (t, 3H, J = 5.7), 0.88 (t, 3H, J = 5.3). 31P-NMR (160 MHz, 
CDCl3): δ 1.051. ESI-MS: 748.6 [M-H]- (C43H76O7PN). 
 
Compound 33 
 Using a procedure similar to that described for the preparation of 14, compound 33 
(17.3 mg, 19.4 µmol, 78%) was obtained. Rf = 0.35 (benzene). Rf = 0.67 




 Using a procedure similar to that described for the preparation of 14, compound 34 
(4.66 mg, 5.10 µmol, 92%) was obtained. Rf = 0.35 (benzene). Rf = 0.67 
(chloroform/methanol/28% NH3 solution = 65:25:4). ESI-MS: 911.4 [M-H]- (C49H77O10PN4) 
 
Compound 35 
 To a stirred mixture of NaH (50.0 mg, 1.25 mmol) in dry THF (16 ml) was added 
dropwise compound 26 (60.3 mg, 0.125 mmol) at 0˚C. After it was stirred at room 
temperature for 30 min and then cooled on ice, iodomethane (285 mg, 2.01 mmol) was slowly 
added to the resulting solution. To the reaction mixture was added water after stirring at 8˚C 
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for 16 h. The mixture was then extracted with ethyl acetate. After the combined organic layers 
were concentrated under reduced pressure, the crude product was purified by flash column 
chromatography (eluted with hexane/ethyl acetate = 90:10 to 80:20) to give compound 35 
(59.7 mg, 0.120 mmol, 94%) as a colorless oil. Rf = 0.49 (hexane/ethyl acetate = 4:1). 
1H-NMR (300 MHz, CDCl3): δ 7.25 (d, 2H, J = 8.4), 6.87 (d, 2H, J = 8.7), 5.44-5.27 (m, 
10H), 4.48 (s, 2H), 3.80 (s, 3H), 3.61-3.41 (m, 7H), 3.35 (s, 3H), 2.88-2.77 (m, 8H), 2.14-2.01 
(m, 4H), 1.60 (tt, 2H, J = 7.4 and 7.4), 1.42 (tt, 2H, J = 7.7 and 7.7), 0.97 (t, 3H, J = 7.5). 
 
Compound 36 
 Using a procedure similar to that described for the preparation of 19, crude 36 was 
obtained, which was purified by flash column chromatography (hexane/ethyl acetate = 80:20), 
yielding compound 36 (8.0 mg, 21.2 µmol, 18%) as a colorless oil. Rf = 0.12 (hexane/ethyl 
acetate = 4:1). 1H-NMR (300 MHz, CDCl3): δ 5.44-5.27 (m, 10H), 3.75-3.43 (m, 7H), 3.37 (s, 
3H), 2.88-2.77 (m, 8H), 2.14-2.01 (m, 4H), 1.60 (tt, 2H, J = 7.2 and 7.2), 1.43 (tt, 2H, J = 7.8 
and 7.8), 0.97 (t, 3H, J = 7.5). 
 
Compound 37 
 Using a procedure similar to that described for the preparation of 13, compound 37 
(4.5 mg, 9.0 µmol, 41%) was obtained. Rf = 0.23 (chloroform/methanol/28% NH3 solution = 
65:25:4). 1H-NMR (400 MHz, CDCl3): δ 8.68-8.42 (br s, 2H), 5.48-5.26 (m, 10H), 4.15-4.04 
(br s, 2H),	  3.91 and 3.87 (dd, 1H, J = 9.3 and 5.3), 3.63-3.38 (m, 5H), 3.37 (s, 3H), 3.23-3.05 
(br s, 2H), 2.88-2.76 (m, 8H), 2.12-2.02 (m, 4H), 1.60 (tt, 2H, J = 7.2 and 7.2), 1.43 (tt, 2H, J 





 Using a procedure similar to that described for the preparation of 14, compound 38 
(4.7 mg, 7.1 µmol, 80%) was obtained. Rf = 0.59 (chloroform/methanol/28% NH3 solution = 
65:25:4). ESI-MS: 661.6 [M-H]- (C32H47O9PN4). 
 
Compound 39 
 In a round bottom flask, an heterogenous mixture of compound 32 (5.0 mg, 6.6 
µmol) dissolved in 0.13 ml of diisopropyl ether and phospholipase A1 solution (0.65 ml of 50 
mM sodium acetate (pH 4) containing 1.6 µl of Lecitase Ultra (phospholipase A1 from 
Thermomyces lanuginosus/Fusarium oxysporum, Novozymes Co. Ltd)) was sonicated at 35 
kHz under a nitrogen atmosphere at 35˚C for 30 min by using an ultrasonic washer (SHARP, 
UT-105S). To the mixture after the reaction was added 1.6 ml of methanol. Then, 3.2 ml of 
hexane/diisopropyl ether (1:1) was added to the mixture followed by removal of the upper 
layer to separate compound 39 and free oleic acid. This wash was repeated three times. Then, 
the crude product was extracted by the method of Bligh and Dyer and used in the next step 
without further purification. Rf = 0.13 (chloroform/methanol/28% NH3 solution = 65:25:4). 
1H-NMR (400 MHz, CDCl3): δ 8.68-8.42 (br s, 2H), 5.48-5.26 (m, 10H), 4.15-4.04 (br s, 2H), 
3.89-3.85 (m, 2H), 3.81-3.71 (m, 2H), 3.63-3.38 (m, 3H), 3.23-3.05 (br s, 2H), 2.88-2.76 (m, 
8H), 2.12-2.02 (m, 4H), 1.60 (tt, 2H, J = 7.2 and 7.2), 1.43 (tt, 2H, J = 7.8 and 7.8), 0.97 (t, 




 Using a procedure similar to that described for the preparation of 14 except for the 
reaction temperature, compound 40 (7.1 mg, 11.2 µmol, 80%) was obtained. The reaction 
temperature was changed from room temperature to 0˚C for specific reaction between the 
amino group and NBD-F. Rf = 0.51 (chloroform/methanol/28% NH3 solution = 65:25:4). 
ESI-MS: 631.6 [M-H]- (C31H45O8PN4). 
 
Fluorescence microscopic analysis 
Fluorescence images of the cells were obtained using an epifluorescence 
microscope (E6F-RFL equipped with ×100 oil objective; Plan Fluor, Nikon, Japan) with a 
super-high pressure mercury lamp (Nikon model HB-10103AF). Fluorescence filters, UV-1A 
(Ex: 365/10, DM: 400, BA: 400) and B-2A (Ex: 450-490, DM: 505, BA: 520), were used for 
Hoechst 33342 fluorescence (Ex: 350 nm, Em: 460 nm) and NBD fluorescence (Ex: 467 nm, 
Em: 540 nm), respectively. Digital images were acquired and analyzed using ImageJ software 
(http://rsbweb.nih.gov/ij/). 
 
ESI-MS analysis of phospholipids 
After the fluorescence microscopic analysis, lipids were extracted from the residual 
sample by the Bligh and Dyer method (2). Chloroform (100 µl) containing 1.14 µM 
1,2-dilauroyl-sn-glycero-3-phosphoethanolamine (DLPE, Avanti Polar Lipids) as the internal 
standard 1 was used for the quantification of phospholipids. The chloroform-soluble fraction 
was dried, suspended in 100 µl of acetonitrile/methanol (2:1 v/v) containing 0.1% (v/v) 
ammonium formate (pH 6.5) and 1.02 µM 1,2-dipalmitoyl-sn-glycero-3-phosphoglycerol 
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(DPPG, Nippon Oil ＆ Fats Co. Ltd) as the internal standard 2, and subjected to ESI-MS/MS 
analysis (Applied Biosystems API3000 LC/MS/MS system). Lipid samples (70 µl) were 
applied directly to the ESI source at a rate of 5 µl/min. The data were collected in the negative 
ion mode from 200 to 1200 m/z. The efficiency of lipid extraction was shown to be almost 
identical among samples by comparing the intensities of the internal standards 1 and 2. 
Experiments were repeated three times and yielded almost identical spectra. The fatty acyl 
residues in phospholipids were analyzed in the precursor ion scan mode. To compare the 
amounts of different NBD-labeled phospholipids incorporated into the cells, the following 
value was used: 
ANBD/Ai.s.2/Ief/A600 -----(1) 
where ANBD is an average area of the particular NBD-labeled phospholipid(s) in the mass 
spectra; Ai.s.2 is an average area of DPPG (internal standard 2) in the mass spectra; Ief is the 
efficiency of lipid extraction, which was calculated by dividing “Ai.s.1 after extraction” by 
“Ai.s.1 before extraction,” where Ai.s.1 is an average area of DLPE (internal standard 1) in the 
mass spectra; and A600 is the absorbance of the culture at 600 nm. 
 
Dithionite assay for measuring lipid distribution in the inner (IM) and outer 
(OM) membranes 
To determine the distribution of NBD-labeled phospholipids in the IM and OM of 
the bacterium, we employed a fluorescence-quenching assay by using sodium dithionite. 
Dithionite quenches NBD fluorescence by reduction and hardly penetrates across the lipid 
bilayer membrane because of its high hydrophilicity. Thus, dithionite can be used to 
determine the distribution of NBD-labeled phospholipids inside and outside the membrane 
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compartments (3-5). For this assay, we prepared the following three samples from S. 
livingstonensis Ac10 grown at 6°C in LB medium for 250 h: non-treated, lysozyme-treated, 
and lysozyme-and-Triton X-100-treated cells (Fig. S1A). Because both OM and IM are intact 
in non-treated cells, dithionite can access only the outer leaflet of OM (OMout), where the 
fluorescence from the NBD-labeled phospholipids is quenched. When the cells are treated 
with lysozyme, the OM is disrupted, and both the inner leaflet of the OM (OMin) and the outer 
leaflet of the IM (IMout), in addition to the OMout, become accessible to dithionite for 
fluorescence quenching. When the cells are treated with lysozyme and Triton X-100, both 
OM and IM are disrupted, and the inner leaflet of the IM (IMin) as well as the OMout, OMin, 
and IMout become accessible to dithionite for fluorescence quenching. To prepare the 
lysozyme-treated sample, 10 mg/ml of lysozyme in buffer A was added to the cells to the 
final concentration of 100 µg/ml, followed by the addition of 1.5 mM EDTA in buffer A to 
the final concentration of 0.5 mM. The sample was incubated on ice for 40 min. To prepare 
the lysozyme-and-Triton X-100-treated cells, 4% (w/v) Triton X-100 in buffer A was added 
to the lysozyme-treated sample to the final concentration of 0.4%, and the sample was 
incubated on ice for 20 min. 
The assay was performed by the following procedure: (i) Cells incubated with 
NBD-labeled phospholipids for 250 h were diluted to A600 = 0.032 with buffer A (0.75M 
sucrose, 10 mM Tris-HCl (pH 7.5)) in a fluorescence cuvette. (ii) The fluorescence emission 
of this solution was recorded at an excitation wavelength of 467 nm and an emission 
wavelength of 540 nm by using a Hitachi 850S Fluorescence Spectrophotometer (Tokyo, 
Japan). (iii) After the fluorescence became constant, 1.0M of sodium dithionite (Na2S2O4) in 
degassed H2O was added at a final concentration of 10 mM, and the decrease in the 
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fluorescence was monitored. Experiments were repeated three times; each experiment yielded 
almost identical spectra. 
Figure S1B shows a typical result of the dithionite assay obtained with the cells 
grown in the presence of Acylalkyl-EPA for 250 h. The degree of fluorescence quenching 
was in accordance with the degree of membrane disruption, verifying the validity of this 
method in determining the membrane localization of the NBD-labeled phospholipids. Each 
curve in Fig. S1B shows that the fluorescence intensity rapidly decreased in the initial stage of 
the reaction for about 2 min, and a very slow decrease of the fluorescence followed. The slow 
decrease is probably due to the slow passage of S2O42- or SO2- radicals across the cell 
membranes and their reaction with NBD inside the membrane compartment (4). The slow 
reaction rate was extrapolated to time zero to determine the degree of “fast” fluorescence 
quenching corresponding to the reduction of the NBD group outside the membrane 
compartment. 
To calculate the amount of NBD-labeled phospholipid inside the membrane 
compartment, which dithionite cannot access, the following equation was used: 
Percentage of the NBD-labeled phospholipid inside the membrane = (Fr – Fap)/(F0 – Fap) × 
100 -----(2) 
Fr is the fluorescence after the reaction with dithionite is complete, Fap is the apparent 
fluorescence of the cells without NBD-labeled phospholipid, and F0 is the fluorescence of the 
cells with NBD-labeled phospholipid before reaction. Fr is obtained by extrapolation of the 
slow reaction rate to time zero. 
 
Fluorescence microscopic analysis of the cells treated with dithionite to 
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quench the fluorescence of NBD-labeled phospholipids in the OMout 
To find out on which membrane and on which side of the membrane the fluorescent 
NBD-labeled phospholipids were enriched after 250 h, we combined fluorescent microscopic 
analysis with the dithionite quenching method. The assay was performed by the following 
procedure: (i) S. livingstonensis Ac10 was cultivated in the presence of Acylalkyl-EPA and 
Lysoalkyl-EPA. The culture (200 µl each) was sampled at 250 h, and the cells were treated 
with Hoechst 33342 (final concentration = 25 µg/ml) for nucleoid labeling, followed by two 
wash with 200 µl of buffer A (0.75 M sucrose, 10 mM Tris-HCl (pH 7.5)). (ii) The cells were 
diluted to A600 = 2.7 with buffer A in a tube at 4°C. (iii) Sodium dithionite (100 mM) in 
degassed H2O at 4°C was added to the suspension at a final concentration of 10 mM, and the 
mixture was incubated at 4°C. (iv) After 10 min of the incubation, the excess amount of 
dithionite was inactivated by the addition of 16% (v/v) of formaldehyde aqueous solution 
(methanol free). (v) Fluorescence images derived from NBD and Hoechst33342 of the cells 
were obtained using an epifluorescence microscope (E6F-RFL equipped with ×100 oil 




Legend to Scheme in Supplemental Data 
 
Scheme S1 
Synthetic scheme of NBD-labeled ether phospholipids, Dialkyl-EPA, Dialkyl-OLA, 
Acylalkyl-EPA, Acylalkyl-OLA, Methylalkyl-EPA and Lysoalkyl-EPA (compound 14, 21, 
34, 33, 38, and 40, respectively). R1COOH; oleic acid (18:19c), R2COOH; eicosapentaenoic 
acid (20:55,8,11,14,17 all cis). Reagents and conditions: a. LiAlH4, THF, rt; b. methanesulfonyl 
chloride, triethylamine, benzene, rt; c. NaH, 5 (1.1 equiv.), DMSO, rt; d. CHCl3/0.5 N 
HCl-MeOH (1:1, v/v); e. triphenylmethyl chloride, diisopropylethylamine, dichloromethane, 
rt; f. powdered KOH, 6 (1.0 equiv.), benzene, 40˚C; g. POCl3, triethylamine, 
trichloroethylene-hexane (91:9, v/v), rt; h. 2-aminoethanol, triethylamine, THF, rt; i. 
2-propanol-20% (v/v) AcOH aq. (2:1, v/v), rt; j. NBD-F, triethylamine, CHCl3, rt; k. 
p-methoxybenzyl chloride, NaH, THF, 70˚C; l. NaH, 5 (2.0 equiv.), DMSO, rt;  m. 
2,3-dichloro-5,6-dicyano-p-benzoquinone, dichloromethane, rt; n. 1 (2.2 equiv.), 
dicyclohexylcarbodiimide, dimethylaminopyridine, CHCl3, rt; o. iodomethane, NaH, THF, rt; 
p. PLA1 (cat.), 1:5 (v/v) ether-aqua solution (50 mM sodium acetate (pH 4)), 35˚C; q. NBD-F, 
triethylamine, CHCl3, 0˚C.  
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Legends to Figures in Supplemental Data 
 
Fig. S1 
Dithionite quenching assay. (A) Schematic diagram of the dithionite quenching assay to 
determine the distribution of NBD-labeled phospholipids in the IM and OM. Dithionite hardly 
penetrates across the lipid bilayer, thus quenching the NBD fluorescence only outside the 
membrane compartments. See text for details. (B) Typical result of the dithionite quenching 
assay for the cells grown in the presence of Acylalkyl-EPA. The assay was performed for the 
intact cells (black), the lysozyme-treated cells (red), and the 
lysozyme-and-TritonX-100-treated cells (blue). The dashed line is the extrapolation of the 
slow quenching curve to time zero. Fr is the intercept of the extrapolated line at time zero, 
indicating the fluorescence that should remain after fast quenching of the NBD fluorescence 
outside the membrane compartments. 
 
Fig. S2 
ESI-MS spectra of the phospholipids extracted from S. livingstonensis Ac10 grown in the 
presence of Diacyl-EPA (A) and Diacyl-OLA (B), in the negative ion scan mode. Spectra 
were measured after 36 h (purple), 60 h (blue), 105 h (green), 130 h (orange), and 166 h (red) 
of cultivation. Relative intensities of different samples were normalized by using the intensity 
of the internal standard (1,2-dilauroyl-sn-glycero-3-phosphoethanolamine). Phospholipids 
increased during cultivation were identified by MS/MS analysis (precursor ion scan and 
product ion scan) and are shown as X/Y-PE or –PG (X, Y = acyl chain, PE = 
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